The primary analysis involved 315 patients with previous TNF antagonist failure ( ie , an inadequate response to , loss of response to , or intolerance of 1 TNF antagonists ) ; we determined the proportion of patients in clinical remission ( CDAI , 150 points ) at week 6 .